Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study
Marjel van Dam(Utrecht University), John J.P. Kastelein(QRx Pharma (United States)), Andries J. Smit(OLVG), Michael R. Hayden(University of British Columbia), Aeilko H. Zwinderman(Amsterdam Neuroscience), August H. M. Smelt(Leiden University Medical Center), Susanne M. Clee(Leiden University Medical Center), Eric de Groot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Roosje Roelants(University of Amsterdam), Albert K. Groen(Amsterdam University Medical Centers), Angie Brooks-Wilson(Xenon Pharmaceuticals (Canada)), G. Kees Hovingh(Novo Nordisk (Denmark))
Cited by 196
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
Huntington disease
|Nature Reviews Disease Primers|2015|1.6k